首页> 美国卫生研究院文献>The Journal of Neuroscience >Resolving Behavioral Output via Chemogenetic Designer Receptors Exclusively Activated by Designer Drugs
【2h】

Resolving Behavioral Output via Chemogenetic Designer Receptors Exclusively Activated by Designer Drugs

机译:通过设计药物独家激活的化学生成设计受体解析行为输出

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Designer receptors exclusively activated by designer drugs (DREADDs) have proven to be highly effective neuromodulatory tools for the investigation of neural circuits underlying behavioral outputs. They exhibit a number of advantages: they rely on cell-specific manipulations through canonical intracellular signaling pathways, they are easy and cost-effective to implement in a laboratory setting, and they are easily scalable for single-region or full-brain manipulations. On the other hand, DREADDs rely on ligand–G-protein-coupled receptor interactions, leading to coarse temporal dynamics. In this review we will provide a brief overview of DREADDs, their implementation, and the advantages and disadvantages of their use in animal systems. We also will provide numerous examples of their use across a broad variety of biomedical research fields.
机译:事实证明,由设计药物(DREADDs)专门激活的设计受体是用于研究行为输出基础的神经回路的高效神经调节工具。它们具有许多优点:它们依靠通过规范的细胞内信号传导途径进行的细胞特异性操作,在实验室环境中易于实施且具有成本效益,并且易于扩展用于单区域或全脑操作。另一方面,DREADDs依赖于配体与G蛋白偶联的受体相互作用,从而导致时间动态变化。在这篇综述中,我们将简要概述DREADD,它们的实现以及它们在动物系统中使用的优缺点。我们还将提供在广泛的生物医学研究领域中使用它们的众多示例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号